234 related articles for article (PubMed ID: 29526557)
1. Intracystic papillary carcinoma of the breast: Experience of a major Chinese cancer center.
Zhang J; Zhang T; Wu N; Zhao X; Wang Q; Jiang Y; Gao M; Gu L
Pathol Res Pract; 2018 Apr; 214(4):579-585. PubMed ID: 29526557
[TBL] [Abstract][Full Text] [Related]
2. Intracystic papillary carcinoma: clinical presentation, patterns of practice, and oncological outcomes.
Hassan Z; Boulos F; Abbas J; El Charif MH; Assi H; Sbaity E
Breast Cancer Res Treat; 2020 Jul; 182(2):317-323. PubMed ID: 32462260
[TBL] [Abstract][Full Text] [Related]
3. Can Sentinel Lymph Node Biopsy Be Spared in Papillary Carcinoma of the Breast?
Wang Y; Lu S; Graves T; Ouseph MM; Resnick MB; Yakirevich E
Clin Breast Cancer; 2017 Apr; 17(2):127-133. PubMed ID: 27692774
[TBL] [Abstract][Full Text] [Related]
4. Intracystic papillary carcinoma of breast: report of three cases and review of the literature.
Dhebri AR; Ahmad A; Shah N; Arora PK
BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23188855
[TBL] [Abstract][Full Text] [Related]
5. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
[TBL] [Abstract][Full Text] [Related]
6. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
Imoto S; Yamauchi C; Komoike Y; Tsugawa K; Yotsumoto D; Wada N; Ueno T; Oba MS; Shien T; Sugae S; Tsuda H; Yoneyama K
Breast Cancer; 2017 May; 24(3):427-432. PubMed ID: 27553957
[TBL] [Abstract][Full Text] [Related]
7. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
Fu Y; Chung D; Cao MA; Apple S; Chang H
Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
[TBL] [Abstract][Full Text] [Related]
8. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
9. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
[TBL] [Abstract][Full Text] [Related]
10. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
11. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival.
Bulte JP; van Wely BJ; Kasper S; Kuijt G; van den Wildenberg FJ; Strobbe LJ; de Wilt JH
Breast Cancer Res Treat; 2013 Jul; 140(1):143-9. PubMed ID: 23793602
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
14. Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society.
Park HS; Chae BJ; Song BJ; Jung SS; Han W; Nam SJ; Youn HJ; Ko BK; Kim DW;
Ann Surg Oncol; 2014 Apr; 21(4):1231-6. PubMed ID: 24318094
[TBL] [Abstract][Full Text] [Related]
15. Intracystic papillary carcinoma: a review of 917 cases.
Grabowski J; Salzstein SL; Sadler GR; Blair S
Cancer; 2008 Sep; 113(5):916-20. PubMed ID: 18661510
[TBL] [Abstract][Full Text] [Related]
16. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
17. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
18. Intracystic papillary carcinoma of the male breast: a case report.
Kinoshita H; Kashiwagi S; Teraoka H; Mori T; Kuroda K; Nanbara M; Noda E; Chikugo T; Hirakawa K; Ohira M
World J Surg Oncol; 2018 Jan; 16(1):15. PubMed ID: 29361955
[TBL] [Abstract][Full Text] [Related]
19. Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon.
Matsen C; Villegas K; Eaton A; Stempel M; Manning A; Cody HS; Morrow M; Heerdt A
Ann Surg Oncol; 2016 Aug; 23(8):2456-61. PubMed ID: 26957506
[TBL] [Abstract][Full Text] [Related]
20. Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of Oncology.
Intra M; Viale G; Vila J; Grana CM; Toesca A; Gentilini O; Galimberti V; Veronesi P; Luini A; Rotmensz N; Bagnardi V; Mattar D; Colleoni M
Ann Surg Oncol; 2015 Jul; 22(7):2372-7. PubMed ID: 25515197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
